These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 19242462)

  • 1. Alzheimer's disease: A prion protein connection.
    Cisse M; Mucke L
    Nature; 2009 Feb; 457(7233):1090-1. PubMed ID: 19242462
    [No Abstract]   [Full Text] [Related]  

  • 2. Cellular prion protein mediates impairment of synaptic plasticity by amyloid-beta oligomers.
    Laurén J; Gimbel DA; Nygaard HB; Gilbert JW; Strittmatter SM
    Nature; 2009 Feb; 457(7233):1128-32. PubMed ID: 19242475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new take on prions: preventing Alzheimer's disease.
    Hooper NM; Turner AJ
    Trends Biochem Sci; 2008 Apr; 33(4):151-5. PubMed ID: 18343669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Soluble prion protein and its N-terminal fragment prevent impairment of synaptic plasticity by Aβ oligomers: Implications for novel therapeutic strategy in Alzheimer's disease.
    Scott-McKean JJ; Surewicz K; Choi JK; Ruffin VA; Salameh AI; Nieznanski K; Costa ACS; Surewicz WK
    Neurobiol Dis; 2016 Jul; 91():124-131. PubMed ID: 26949218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Partial reduction of BACE1 improves synaptic plasticity, recent and remote memories in Alzheimer's disease transgenic mice.
    Kimura R; Devi L; Ohno M
    J Neurochem; 2010 Apr; 113(1):248-61. PubMed ID: 20089133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of the nitric oxide pathway in synaptic dysfunction following amyloid elevation in Alzheimer's disease.
    Puzzo D; Palmeri A; Arancio O
    Rev Neurosci; 2006; 17(5):497-523. PubMed ID: 17180876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of β
    Chai GS; Wang YY; Zhu D; Yasheng A; Zhao P
    Neurosci Lett; 2017 Jan; 636():158-164. PubMed ID: 27838449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prion protein in Alzheimer's pathogenesis: a hot and controversial issue.
    Benilova I; De Strooper B
    EMBO Mol Med; 2010 Aug; 2(8):289-90. PubMed ID: 20698011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extracellular Forms of Aβ and Tau from iPSC Models of Alzheimer's Disease Disrupt Synaptic Plasticity.
    Hu NW; Corbett GT; Moore S; Klyubin I; O'Malley TT; Walsh DM; Livesey FJ; Rowan MJ
    Cell Rep; 2018 May; 23(7):1932-1938. PubMed ID: 29768194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synaptic activity reduces intraneuronal Abeta, promotes APP transport to synapses, and protects against Abeta-related synaptic alterations.
    Tampellini D; Rahman N; Gallo EF; Huang Z; Dumont M; Capetillo-Zarate E; Ma T; Zheng R; Lu B; Nanus DM; Lin MT; Gouras GK
    J Neurosci; 2009 Aug; 29(31):9704-13. PubMed ID: 19657023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impairment in hippocampal long-term potentiation in mice under-expressing the Alzheimer's disease related gene presenilin-1.
    Morton RA; Kuenzi FM; Fitzjohn SM; Rosahl TW; Smith D; Zheng H; Shearman M; Collingridge GL; Seabrook GR
    Neurosci Lett; 2002 Feb; 319(1):37-40. PubMed ID: 11814648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prion protein and Abeta-related synaptic toxicity impairment.
    Calella AM; Farinelli M; Nuvolone M; Mirante O; Moos R; Falsig J; Mansuy IM; Aguzzi A
    EMBO Mol Med; 2010 Aug; 2(8):306-14. PubMed ID: 20665634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prions, prionoids and pathogenic proteins in Alzheimer disease.
    Ashe KH; Aguzzi A
    Prion; 2013; 7(1):55-9. PubMed ID: 23208281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High molecular mass assemblies of amyloid-β oligomers bind prion protein in patients with Alzheimer's disease.
    Dohler F; Sepulveda-Falla D; Krasemann S; Altmeppen H; Schlüter H; Hildebrand D; Zerr I; Matschke J; Glatzel M
    Brain; 2014 Mar; 137(Pt 3):873-86. PubMed ID: 24519981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alzheimer's disease: Recollection of lost memories.
    Malenka RC; Malinow R
    Nature; 2011 Jan; 469(7328):44-5. PubMed ID: 21209657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Probiotic treatment improves the impaired spatial cognitive performance and restores synaptic plasticity in an animal model of Alzheimer's disease.
    Rezaei Asl Z; Sepehri G; Salami M
    Behav Brain Res; 2019 Dec; 376():112183. PubMed ID: 31472194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinct prion-like strains of amyloid beta implicated in phenotypic diversity of Alzheimer's disease.
    Cohen M; Appleby B; Safar JG
    Prion; 2016; 10(1):9-17. PubMed ID: 26809345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alzheimer's disease.
    Querfurth HW; LaFerla FM
    N Engl J Med; 2010 Jan; 362(4):329-44. PubMed ID: 20107219
    [No Abstract]   [Full Text] [Related]  

  • 19. Early-onset familial Alzheimer disease with coexisting beta-amyloid and prion pathology.
    Leuba G; Saini K; Savioz A; Charnay Y
    JAMA; 2000 Apr; 283(13):1689-91. PubMed ID: 10755493
    [No Abstract]   [Full Text] [Related]  

  • 20. Ablating ErbB4 in PV neurons attenuates synaptic and cognitive deficits in an animal model of Alzheimer's disease.
    Zhang H; Zhang L; Zhou D; He X; Wang D; Pan H; Zhang X; Mei Y; Qian Q; Zheng T; Jones FE; Sun B
    Neurobiol Dis; 2017 Oct; 106():171-180. PubMed ID: 28684271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.